Welcome to the Swedish Medical Products Agency

The Swedish Medical Products Agency (MPA) is the Swedish national authority responsible for regulation and surveillance of the development, manufacturing and marketing of drugs and other medicinal products. Our task is to ensure that both the individual patient and healthcare professionals have access to safe and effective medicinal products and that these are used in a rational and cost-effective manner.

 

BREXIT requires changes of Reference Member State for MRP/DCP-approved medicinal products

When UK leaves the EU, change of Reference Member State for MRP/DCP-approved products with UK as RMS is required. The Swedish Medical Products Agency welcome requests for Sweden to act as Reference Member State (RMS) for medicines authorised in MRP/DCP with UK as RMS today.

 Read more

 

The Swedish pharmacy market

Since July 1, 2009, private pharmacies are allowed in Sweden. The re-regulation of the Swedish pharmacy market is expected to lead to more pharmacies and more generous opening hours.

 The Swedish pharmacy market  

Scientific advice

It is the MPA´s responsibility to give the industry advice by answering questions connected with the development of medical products based on the applicant’s documentation. Advice may be requested for all medical products, irrespective of subsequent choice of procedure for approval.

 Scientific advice

 
 
 
NEWS
About the web site
The Swedish Medical Products Agency makes every effort to ensure the quality of the information available on this website and updates the information regularly. The topics covered on the English section are not equivalent to the Swedish.
 

Swedish Medical Products Agency, P.O. Box 26, SE-751 03 Uppsala, SWEDEN | +46 18 17 46 00 | registrator@mpa.se | Contact information